Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Jincheng Jinsu Pharmaceutical is a prominent Chinese pharmaceutical manufacturer specializing in anti-infective therapies, particularly cephalosporin antibiotics. Based in Zhongshan, Guangdong, the company operates as a key subsidiary of the publicly traded Shandong Jincheng Pharmaceutical Group. Its core business revolves around the production of sterile powder for injection, with a product line featuring essential antibiotics like Cefazolin, Cefuroxime, and Ceftriaxone. The facility is GMP-certified and serves as a critical manufacturing hub within the parent company's vertically integrated supply chain. Jincheng Jinsu is recognized for its high production capacity and its role in providing high-quality generic medications to both the Chinese domestic market and international regions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Jincheng Jinsu Pharmaceutical.